-
公开(公告)号:US5672508A
公开(公告)日:1997-09-30
申请号:US589981
申请日:1996-01-23
申请人: Jeno Gyuris , Lou Lamphere , David Beach
发明人: Jeno Gyuris , Lou Lamphere , David Beach
IPC分类号: A01K67/027 , A61K31/00 , A61K35/76 , A61K38/00 , A61K38/45 , A61K48/00 , A61P9/00 , A61P9/10 , A61P17/00 , A61P17/14 , A61P25/28 , A61P35/00 , A61P43/00 , C07K14/47 , C07K19/00 , C12N15/09 , C12N15/62 , C07H21/04
CPC分类号: C07K14/4738 , A01K2217/05 , A61K38/00 , C07K2319/00 , C07K2319/02 , C07K2319/10 , C12N2799/022 , C12N2799/026 , C12N2799/027
摘要: The present invention pertains to novel inhibitors of cyclin-dependent kinases (CDKs), particularly CDK/cyclin complexes, which inhibitors can be used to control proliferation and/or differentiation of cells in which the inhibitors are introduced. More specifically, the inhibitors of the invention are chimeric proteins which include CDK-binding motifs from two or more different proteins. For example, the subject chimeric proteins can be generated from the in-frame fusion of coding sequences from two different CDK inhibitor proteins, such as may be derived from fusion of coding sequences for an INK4 protein and coding sequences for a CIP protein. Chimeric proteins of the present invention have been observed to be more potent inhibitors of cyclin/CDK complexes than were either of the portions of the chimeric protein individually.
摘要翻译: 本发明涉及细胞周期蛋白依赖性激酶(CDK)的新型抑制剂,特别是CDK /细胞周期蛋白复合物,该抑制剂可用于控制其中引入抑制剂的细胞的增殖和/或分化。 更具体地,本发明的抑制剂是包含来自两种或更多种不同蛋白质的CDK结合基序的嵌合蛋白质。 例如,可以从来自两种不同CDK抑制剂蛋白质的编码序列的框内融合产生受试者嵌合蛋白,例如可衍生自INK4蛋白的编码序列的融合和CIP蛋白的编码序列。 已经观察到本发明的嵌合蛋白比单独的嵌合蛋白的部分中的任一部分更有效的细胞周期蛋白/ CDK复合物抑制剂。
-
2.
公开(公告)号:US5756671A
公开(公告)日:1998-05-26
申请号:US625209
申请日:1996-04-01
申请人: Jeno Gyuris , Lou Lamphere , Giulio Draetta
发明人: Jeno Gyuris , Lou Lamphere , Giulio Draetta
CPC分类号: C12N9/1205 , C07K14/4738 , C12N9/12 , A01K2217/05 , A61K38/00 , C07K2319/00
摘要: The present invention relates to the discovery in mammalian cells, particularly human cells, of a novel CDK-binding protein, referred to herein as "cdc37". As described herein, this protein functions to facilitate activation and accordingly functions in the modulation of cell-cycle progression, and therefore ultimately of cell growth and differentiation. Moreover, binding data indicated that cdc37 may function coordinately with other cell-cycle regulatory proteins, such as of cyclin-dependent kinases (CDKs), src, p53 and erk kinases.
摘要翻译: 本发明涉及在哺乳动物细胞,特别是人类细胞中发现新的CDK结合蛋白,本文称为“cdc37”。 如本文所述,该蛋白质起到促进活化作用的作用,因此起到调节细胞周期进程的作用,从而最终导致细胞生长和分化。 此外,结合数据表明cdc37可以与其他细胞周期调节蛋白(例如细胞周期蛋白依赖性激酶(CDK)),src,p53和erk激酶协调起作用。
-
公开(公告)号:US6015692A
公开(公告)日:2000-01-18
申请号:US853733
申请日:1997-05-09
申请人: Jeno Gyuris , Lou Lamphere , Giulio Draetta
发明人: Jeno Gyuris , Lou Lamphere , Giulio Draetta
CPC分类号: C12N9/1205 , C07K14/4738 , C12N9/12 , A01K2217/05 , A61K38/00 , C07K2319/00
摘要: The present invention relates to the discovery in mammalian cells, particularly human cells, of a novel CDK-binding protein, referred to herein as "cdc37". As described herein, this protein functions to facilitate activation and accordingly finctions in the modulation of cell-cycle progression, and therefore ultimately of cell growth and differentiation. Moreover, binding data indicated that cdc37 may function coordinately with other cell-cycle regulatory proteins, such as of cyclin-dependent kinases (CDKs), src, p53 and erk kinases.
摘要翻译: 本发明涉及在哺乳动物细胞,特别是人类细胞中发现新的CDK结合蛋白,本文称为“cdc37”。 如本文所述,该蛋白质有助于促进细胞周期进程的调节和因此最终细胞生长和分化的激活和因此的功能。 此外,结合数据表明cdc37可以与其他细胞周期调节蛋白(例如细胞周期蛋白依赖性激酶(CDK)),src,p53和erk激酶协调起作用。
-
公开(公告)号:US06495526B2
公开(公告)日:2002-12-17
申请号:US08902572
申请日:1997-07-29
申请人: Jeno Gyuris , Lou Lamphere , David H. Beach
发明人: Jeno Gyuris , Lou Lamphere , David H. Beach
IPC分类号: A61K4800
CPC分类号: C07K14/47 , A01K2217/05 , A61K38/00 , C07K14/4738 , C07K2319/00 , C07K2319/02 , C07K2319/10 , C12N15/62 , C12N2799/022 , C12N2799/026 , C12N2799/027
摘要: The present invention pertains to novel inhibitors of cyclin-dependent kinases (CDKs), particularly CDK/cyclin complexes, which inhibitors can be used to control proliferation and/or differentiation of cells in which the inhibitors are introduced.
摘要翻译: 本发明涉及细胞周期蛋白依赖性激酶(CDK)的新型抑制剂,特别是CDK /细胞周期蛋白复合物,该抑制剂可用于控制其中引入抑制剂的细胞的增殖和/或分化。
-
公开(公告)号:US08575318B2
公开(公告)日:2013-11-05
申请号:US13589652
申请日:2012-08-20
申请人: May Han , S. Kirk Wright , William M. Winston, Jr. , Lyne Breault , Jie Lin , Bijan Etemad-Gilbertson , Christine Knuehl , Jeno Gyuris
发明人: May Han , S. Kirk Wright , William M. Winston, Jr. , Lyne Breault , Jie Lin , Bijan Etemad-Gilbertson , Christine Knuehl , Jeno Gyuris
CPC分类号: C07K16/22 , A61K2039/505 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92
摘要: The present invention provides a family of binding proteins that bind and neutralize the activity of hepatocyte growth factor (HGF), in particular human HGF. The binding proteins can be used as diagnostic and/or therapeutic agents. With regard to their therapeutic activity, the binding proteins can be used to treat certain HGF responsive disorders, for example, certain HGF responsive tumors.
摘要翻译: 本发明提供结合并中和肝细胞生长因子(HGF),特别是人HGF的活性的结合蛋白家族。 结合蛋白可用作诊断和/或治疗剂。 关于它们的治疗活性,结合蛋白可用于治疗某些HGF应答性病症,例如某些HGF反应性肿瘤。
-
公开(公告)号:US20080108565A1
公开(公告)日:2008-05-08
申请号:US11757059
申请日:2007-06-01
申请人: William M. Winston, Jr. , S. Kirk Wright , May Han , Lyne Breault , Jie Lin , Bijan Etemad-Gilbertson , Christine Knuehl , Jeno Gyuris , Arnold Horwitz
发明人: William M. Winston, Jr. , S. Kirk Wright , May Han , Lyne Breault , Jie Lin , Bijan Etemad-Gilbertson , Christine Knuehl , Jeno Gyuris , Arnold Horwitz
CPC分类号: C07K16/22 , A61K2039/505 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92
摘要: The present invention provides a family of binding proteins that bind and neutralize the activity of hepatocyte growth factor (HGF), in particular human HGF. The binding proteins can be used as diagnostic and/or therapeutic agents. With regard to their therapeutic activity, the binding proteins can be used to treat certain HGF responsive disorders, for example, certain HGF responsive tumors.
-
公开(公告)号:US06420110B1
公开(公告)日:2002-07-16
申请号:US09174943
申请日:1998-10-19
申请人: Jeno Gyuris , Aaron J. Morris
发明人: Jeno Gyuris , Aaron J. Morris
IPC分类号: C12Q170
CPC分类号: C40B40/02 , C12N15/1037
摘要: One aspect of the present invention is the synthesis of a binary method that combines variegated peptide display libraries, e.g., in a “display mode”, with soluble secreted peptide libraries, e.g., in a “secretion mode”, to yield a method for the efficient isolation of peptides having a desired biological activity.
-
公开(公告)号:US20110256154A1
公开(公告)日:2011-10-20
申请号:US13082852
申请日:2011-04-08
申请人: Sylvie Vincent , William M. Winston, JR. , Fang Wang , Solly Weiler , Kristan Meetze , Lyne Breault , Steve Botega , Ting Chen , Michael DePrima , Christina Fleet , Steven Tyler , Jin-Kyeung Woo , Jeno Gyuris
发明人: Sylvie Vincent , William M. Winston, JR. , Fang Wang , Solly Weiler , Kristan Meetze , Lyne Breault , Steve Botega , Ting Chen , Michael DePrima , Christina Fleet , Steven Tyler , Jin-Kyeung Woo , Jeno Gyuris
IPC分类号: A61K39/395 , C07H21/00 , C12P21/00 , C12N15/63 , C12N1/00 , C12N5/10 , C07K16/28 , A61P35/00
CPC分类号: C07K16/32 , A61K39/39558 , A61K2039/505 , C07K16/30 , C07K2317/24 , C07K2317/51 , C07K2317/515 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92
摘要: Monoclonal antibodies that bind and inhibit activation of epidermal growth factor receptor related member ErbB3/HER3 are disclosed. The antibodies can be used to treat cell proliferative diseases and disorders, including certain forms of cancer, associated with activation of ErbB3/HER3.
摘要翻译: 公开了结合并抑制表皮生长因子受体相关成分ErbB3 / HER3活化的单克隆抗体。 抗体可用于治疗与ErbB3 / HER3的激活相关的细胞增殖性疾病和病症,包括某些形式的癌症。
-
公开(公告)号:US20110236377A1
公开(公告)日:2011-09-29
申请号:US13051474
申请日:2011-03-18
申请人: May Han , S. Kirk Wright , William M. Winston, JR. , Lyne Breault , Jie Lin , Bijan Etemad-Gilbertson , Christine Knuehl , Jeno Gyuris
发明人: May Han , S. Kirk Wright , William M. Winston, JR. , Lyne Breault , Jie Lin , Bijan Etemad-Gilbertson , Christine Knuehl , Jeno Gyuris
IPC分类号: A61K39/395 , C12N5/02 , A61P35/00
CPC分类号: C07K16/22 , A61K2039/505 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92
摘要: The present invention provides a family of binding proteins that bind and neutralize the activity of hepatocyte growth factor (HGF), in particular human HGF. The binding proteins can be used as diagnostic and/or therapeutic agents. With regard to their therapeutic activity, the binding proteins can be used to treat certain HGF responsive disorders, for example, certain HGF responsive tumors.
摘要翻译: 本发明提供结合并中和肝细胞生长因子(HGF),特别是人HGF的活性的结合蛋白家族。 结合蛋白可用作诊断和/或治疗剂。 关于它们的治疗活性,结合蛋白可用于治疗某些HGF应答性病症,例如某些HGF反应性肿瘤。
-
公开(公告)号:US20110229462A1
公开(公告)日:2011-09-22
申请号:US13051481
申请日:2011-03-18
申请人: William M. Winston, JR. , S. Kirk Wright , May Han , Lyne Breault , Jie Lin , Bijan Etemad-Gilbertson , Christine Knuehl , Jeno Gyuris , Arnold Horwitz
发明人: William M. Winston, JR. , S. Kirk Wright , May Han , Lyne Breault , Jie Lin , Bijan Etemad-Gilbertson , Christine Knuehl , Jeno Gyuris , Arnold Horwitz
IPC分类号: A61K39/395 , A61P35/00 , C12N5/09
CPC分类号: C07K16/22 , A61K2039/505 , C07K2317/24 , C07K2317/56 , C07K2317/565 , C07K2317/73 , C07K2317/76 , C07K2317/92
摘要: The present invention provides a family of binding proteins that bind and neutralize the activity of hepatocyte growth factor (HGF), in particular human HGF. The binding proteins can be used as diagnostic and/or therapeutic agents. With regard to their therapeutic activity, the binding proteins can be used to treat certain HGF responsive disorders, for example, certain HGF responsive tumors.
-
-
-
-
-
-
-
-
-